Sprint Bioscience (Sweden) Market Value
| SPRINT Stock | SEK 1.82 0.02 1.09% |
| Symbol | Sprint |
Sprint Bioscience 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to Sprint Bioscience's stock what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of Sprint Bioscience.
| 10/31/2024 |
| 11/30/2024 |
If you would invest 0.00 in Sprint Bioscience on October 31, 2024 and sell it all today you would earn a total of 0.00 from holding Sprint Bioscience AB or generate 0.0% return on investment in Sprint Bioscience over 30 days. Sprint Bioscience is related to or competes with Kancera AB, Lidds AB, Cantargia, and Xintela AB. Sprint Bioscience AB develops pharmaceutical products in the areas of cancer and metabolism More
Sprint Bioscience Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure Sprint Bioscience's stock current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess Sprint Bioscience AB upside and downside potential and time the market with a certain degree of confidence.
| Downside Deviation | 5.14 | |||
| Information Ratio | 0.0888 | |||
| Maximum Drawdown | 29.57 | |||
| Value At Risk | (5.81) | |||
| Potential Upside | 9.88 |
Sprint Bioscience Market Risk Indicators
Today, many novice investors tend to focus exclusively on investment returns with little concern for Sprint Bioscience's investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as Sprint Bioscience's standard deviation. In reality, there are many statistical measures that can use Sprint Bioscience historical prices to predict the future Sprint Bioscience's volatility.| Risk Adjusted Performance | 0.0978 | |||
| Jensen Alpha | 0.5934 | |||
| Total Risk Alpha | (0.26) | |||
| Sortino Ratio | 0.0847 | |||
| Treynor Ratio | (2.39) |
Sprint Bioscience Backtested Returns
Sprint Bioscience appears to be dangerous, given 3 months investment horizon. Sprint Bioscience owns Efficiency Ratio (i.e., Sharpe Ratio) of 0.13, which indicates the firm had a 0.13% return per unit of risk over the last 3 months. By inspecting Sprint Bioscience's technical indicators, you can evaluate if the expected return of 0.62% is justified by implied risk. Please review Sprint Bioscience's Risk Adjusted Performance of 0.0978, semi deviation of 4.22, and Coefficient Of Variation of 855.69 to confirm if our risk estimates are consistent with your expectations. On a scale of 0 to 100, Sprint Bioscience holds a performance score of 9. The entity has a beta of -0.24, which indicates not very significant fluctuations relative to the market. As returns on the market increase, returns on owning Sprint Bioscience are expected to decrease at a much lower rate. During the bear market, Sprint Bioscience is likely to outperform the market. Please check Sprint Bioscience's potential upside, as well as the relationship between the kurtosis and day typical price , to make a quick decision on whether Sprint Bioscience's existing price patterns will revert.
Auto-correlation | -0.9 |
Excellent reverse predictability
Sprint Bioscience AB has excellent reverse predictability. Overlapping area represents the amount of predictability between Sprint Bioscience time series from 31st of October 2024 to 15th of November 2024 and 15th of November 2024 to 30th of November 2024. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of Sprint Bioscience price movement. The serial correlation of -0.9 indicates that approximately 90.0% of current Sprint Bioscience price fluctuation can be explain by its past prices.
| Correlation Coefficient | -0.9 | |
| Spearman Rank Test | -0.71 | |
| Residual Average | 0.0 | |
| Price Variance | 0.02 |
Sprint Bioscience lagged returns against current returns
Autocorrelation, which is Sprint Bioscience stock's lagged correlation, explains the relationship between observations of its time series of returns over different periods of time. The observations are said to be independent if autocorrelation is zero. Autocorrelation is calculated as a function of mean and variance and can have practical application in predicting Sprint Bioscience's stock expected returns. We can calculate the autocorrelation of Sprint Bioscience returns to help us make a trade decision. For example, suppose you find that Sprint Bioscience has exhibited high autocorrelation historically, and you observe that the stock is moving up for the past few days. In that case, you can expect the price movement to match the lagging time series.
Current and Lagged Values |
| Timeline |
Sprint Bioscience regressed lagged prices vs. current prices
Serial correlation can be approximated by using the Durbin-Watson (DW) test. The correlation can be either positive or negative. If Sprint Bioscience stock is displaying a positive serial correlation, investors will expect a positive pattern to continue. However, if Sprint Bioscience stock is observed to have a negative serial correlation, investors will generally project negative sentiment on having a locked-in long position in Sprint Bioscience stock over time.
Current vs Lagged Prices |
| Timeline |
Sprint Bioscience Lagged Returns
When evaluating Sprint Bioscience's market value, investors can use the concept of autocorrelation to see how much of an impact past prices of Sprint Bioscience stock have on its future price. Sprint Bioscience autocorrelation represents the degree of similarity between a given time horizon and a lagged version of the same horizon over the previous time interval. In other words, Sprint Bioscience autocorrelation shows the relationship between Sprint Bioscience stock current value and its past values and can show if there is a momentum factor associated with investing in Sprint Bioscience AB.
Regressed Prices |
| Timeline |
Thematic Opportunities
Explore Investment Opportunities
Other Information on Investing in Sprint Stock
Sprint Bioscience financial ratios help investors to determine whether Sprint Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Sprint with respect to the benefits of owning Sprint Bioscience security.